Tumour Biomarkers
Cancer treatment has long been a complex challenge, but precision oncology has transformed the field by driving the development of targeted therapies and refining existing approaches. At the heart of this revolution are molecular biomarkers, essential tools for identifying patients who will benefit most from personalized treatments. Biomarkers have vast potential in oncology, aiding in risk assessment, screening, prognosis, diagnosis, treatment response prediction, and disease monitoring. Several biomarkers are already integral to clinical practice. As biomarker research accelerates, it is critical to search for markers with greater sensitivity, specificity, and predictive power. These advancements improve diagnostic accuracy and therapeutic outcomes, ultimately enhancing cancer care and patient survival.